Recent Updates
Recently added Catalysts
MNKD

MannKind to Present at Upcoming Conferences

Key Takeaway: VALENCIA, Calif., May 27, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at upcoming conferences. Jefferies 2015 Global Healthcare Conference on Wed

Full Press Release Details

VALENCIA, Calif., May 27, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at upcoming conferences.
Jefferies 2015 Global Healthcare Conference on Wednesday, June 3, 2015 at 2:00 pm (ET) in New York, New York.
Goldman Sachs 36th Annual Global Healthcare Conference on Wednesday, June 10, 2015 at 8:40 am (PT) at the Terranea Resort in Rancho Palos Verdes, California.
JMP Securities Life Sciences Conference on Wednesday, June 24, 2015 at 9:30 am (ET) at the St. Regis Hotel in New York, New York.
Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com.
About MannKind Corporation
MannKind Corporation (Nasdaq:MNKD) focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

Tags

Last updated: May 27, 2015